Indication intelligence, analysis and sector perception

Precigen (PGEN) $75 M offering priced at $1.75

January 25, 2023

PGEN closed up (Tuesday) +$0.02 to $2.19 with a market response to the S-3 of -$0.60 or -27.625% to $1.59  Also granted the underwriters a 30-day option to purchase up to an additional $11.25 M of its common stock.

Verastem Oncology (VSTM) $60 M Private Placement Offering of Series B Convertible Preferred Stock

January 24, 2023

Definitive agreement to sell approximately 2.1 million shares of its Series B Convertible Preferred Stock to affiliates of BVF Partners L.P. of $60 million in two tranches VSTM closed up +$0.02 to $0.61 with a negative -$0.01 or -1.66% aftermarket - so far and STILL de-listed from Nasdaq

bluebird bio (BLUE) prices offering of 20 M shares at $6.00

January 18, 2023

BLUE priced at $6.00, the aftermarket is up +$0.12 or +2.07%  BLUE also intends to grant the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of its common stock to be sold in the offering.